Law360, New York (May 05, 2008, 12:00 AM ET) -- Drug distributor McKesson Corp. has agreed to pay $13.25 million to settle allegations made by six U.S. attorney's offices that the company violated federal reporting provisions in its handling of hydrocodone and alprazolam.
The administrative settlement, which resolves the matter, also calls for a temporary suspension of distribution of the two drugs from two of McKesson’s 31 distribution centers, the company said Friday. McKesson said that it will also tighten its monitoring and reporting procedures for orders for controlled substances.
The California-based company did not admit...
McKesson Ponies Up $13M To Settle Drug Claims
To view the full article, take a free trial now.
